R01 CA118386-01/CA/NCI NIH HHS/United States[Grants and Funding] - Search Results

Save citations to file

Email citations

Your saved search

Your RSS Feed

Year	Number of Results
2009	1
2011	1
2012	1
2024	0

Page 1

The present and future of peptide vaccines for cancer: single or multiple, long or short, alone or in combination?

Slingluff CL Jr. Slingluff CL Jr. Cancer J. 2011 Sep-Oct;17(5):343-50. doi: 10.1097/PPO.0b013e318233e5b2. Cancer J. 2011. PMID: 21952285 Free PMC article. Review.

The vaccine-site microenvironment induced by injection of incomplete Freund's adjuvant, with or without melanoma peptides.

Harris RC, Chianese-Bullock KA, Petroni GR, Schaefer JT, Brill LB 2nd, Molhoek KR, Deacon DH, Patterson JW, Slingluff CL Jr. Harris RC, et al. J Immunother. 2012 Jan;35(1):78-88. doi: 10.1097/CJI.0b013e31823731a4. J Immunother. 2012. PMID: 22130163 Free PMC article. Clinical Trial.

Multi-peptide vaccines vialed as peptide mixtures can be stable reagents for use in peptide-based immune therapies.

Chianese-Bullock KA, Lewis ST, Sherman NE, Shannon JD, Slingluff CL Jr. Chianese-Bullock KA, et al. Vaccine. 2009 Mar 10;27(11):1764-70. doi: 10.1016/j.vaccine.2009.01.018. Epub 2009 Feb 8. Vaccine. 2009. PMID: 19185050 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3 results

Results by year

Search Page

Filters

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

3 results

Results by year